BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS Share Price

Certificat

PX88S

DE000SU0YN42

Market Closed - Euronext Paris 17:30:01 14/05/2024 BST
4.911 EUR -6.39% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS
Current month+6.09%
1 month-5.90%
Date Price Change
14/05/24 4.911 -6.39%
13/05/24 5.246 +3.47%
10/05/24 5.07 +3.91%
09/05/24 4.879 +1.86%
08/05/24 4.79 +1.25%

Real-time Euronext Paris

Last update May 14, 2024 at 05:30 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
PX88S
ISINDE000SU0YN42
Date issued 20/10/2023
Strike 176.3 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 6.61
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 8.39
Lowest since issue 3.797

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
224.6 CHF
Average target price
279.4 CHF
Spread / Average Target
+24.39%
Consensus
  1. Stock Market
  2. Certificates
  3. PX88S Certificat